Measuring proteins in blood for personalized care in type 1 diabetes
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
This project is developing new ways to measure proteins in your blood to better understand, predict, and personalize care for type 1 diabetes.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11118936 on NIH RePORTER |
What this research studies
Type 1 diabetes is a challenging condition, and we currently lack good ways to predict or prevent it. This project focuses on finding better ways to measure specific proteins in your blood that can act as 'biomarkers'. Researchers are using advanced technology called mass spectrometry, which is very precise, to identify these proteins. They are also exploring new techniques to make these measurements even more sensitive, hoping to improve how we understand and treat the disease.
Who could benefit from this research
Good fit: This research is relevant for individuals living with type 1 diabetes, especially those interested in new diagnostic and monitoring tools.
Not a fit: Patients without type 1 diabetes would not directly benefit from the findings of this specific protein measurement research.
Why it matters
Potential benefit: If successful, this work could lead to earlier prediction, better prevention strategies, and more tailored treatments for individuals with type 1 diabetes.
How similar studies have performed: While mass spectrometry techniques have shown promise in other areas, this project aims to develop novel, highly specific protein assays for type 1 diabetes using new enrichment methods.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Hoofnagle, Andrew N — University of Washington
- Study coordinator: Hoofnagle, Andrew N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.